Clinical Trial Update: Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma. [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, cross-over trial comparing three once-daily doses of tiotropium with placebo in adults with moderate persistent asthma, evalua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-21